Related Experiment Video
Updated: Aug 23, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
BMI Modifies Increased Mortality Risk of Post-PCI STEMI Patients with AKI
Reut Schvartz1, Lior Lupu2, Shir Frydman2
1Department of Anesthesia Pain and Intensive Care, Tel Aviv Sourasky Medical Center, Tel Aviv 62431, Israel.
Insights
Acute kidney injury (AKI) increases mortality in ST-elevation myocardial infarction (STEMI) patients post-percutaneous coronary intervention (PCI). However, higher body mass index (BMI) shows a protective effect, improving survival rates in these high-risk patients.
Area of Science:
- Cardiology
- Nephrology
- Critical Care Medicine
Background:
- Acute ST-elevation myocardial infarction (STEMI) mortality reduced by percutaneous coronary intervention (PCI).
- Acute kidney injury (AKI) remains a significant predictor of mortality in STEMI patients post-PCI.
- Overweight's protective role in STEMI and AKI separately is known, but not concurrently.
Purpose of the Study:
- To investigate the association between AKI and mortality in STEMI patients undergoing PCI.
- To determine if body mass index (BMI) offers a protective effect on mortality in this patient cohort.
Main Methods:
- Retrospective analysis of 2,141 STEMI patients undergoing PCI from 2008-2016.
- Comparison of all-cause mortality between patients with and without AKI post-PCI.
- Logistic regression and survival analyses to assess the impact of AKI and BMI on mortality.
Main Results:
- 178 patients (10%) developed AKI, associated with significantly higher 30-day and overall mortality (p < 0.001).
- Logistic regression confirmed AKI as a significant risk factor for mortality.
- Higher BMI demonstrated a significant protective effect on both 30-day and overall survival.
Conclusions:
- AKI is a major risk factor for mortality and poor survival following PCI for STEMI.
- Increased BMI may have a beneficial, protective effect on survival in STEMI patients who develop AKI post-PCI.
Abstract:
Mortality from acute ST elevation myocardial infarction (STEMI) was significantly reduced with the introduction of percutaneous catheterization intervention (PCI) but remains high in patients who develop acute kidney injury (AKI). Previous studies found overweight to be protective from mortality in patients suffering from STEMI and AKI separately but not as they occur concurrently. This study aimed to establish the relationship between AKI and mortality in STEMI patients after PCI and whether body mass index (BMI) has a protective impact. Between January 2008 and June 2016, two thousand one hundred and forty-one patients with STEMI underwent PCI and were admitted to the Tel Aviv Medical Center Cardiac Intensive Care Unit. Their demographic, laboratory, and clinical data were collected and analyzed. We compared all-cause mortality in patients who developed AKI after PCI for STEMI and those who did not. In total, 178 patients (10%) developed AKI and had higher mortality (p < 0.001). Logistic regression analysis was performed to determine the relationship between AKI, BMI, and mortality. AKI was significantly associated with both 30-day and overall mortality, while BMI had a significant protective effect. Survival analysis found a significant difference in 30-day and overall survival between patients with and without AKI with a significant protective effect of BMI on survival at 30 days. AKI presents a major risk for mortality and poor survival after PCI for STEMI, yet a beneficial effect of increased BMI modifies it.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Coronary Syndrome IV: Interprofessional Care
Acute Kidney Injury I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies

